Nuvation Bio Inc.
NUVB
$6.26
+7.93%
NUVB price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nuvation Bio Inc.'s 12-month outlook, with a consensus price target around $12.33 and implied upside of +97.0% versus the current price.
Average Target
$12.33
0 analysts
Implied Upside
+97.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$7 - $19
Analyst target range
NUVB Technical Analysis
Beta
1.53
1.53x market volatility
Max Drawdown
-57.5%
Largest decline past year
52-Week Range
$2-$10
Price range past year
Annual Return
+172.2%
Cumulative gain past year
| Period | NUVB Return | S&P 500 |
|---|---|---|
| 1m | +12.6% | -0.6% |
| 3m | +22.5% | +5.4% |
| 6m | +1.8% | +8.3% |
| 1y | +172.2% | +18.3% |
| ytd | -27.0% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is NUVB Overvalued?
PE
-14.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-15.4x
Enterprise Value Multiple